For Investors and Analysts Autolus Therapeutics is excited to be attending the European Hematology Association (EHA) meeting in IFEMA MADRID and presenting three clinical data updates:
Autolus Therapeutics’ Post
More Relevant Posts
-
Thank you to our hosts and sponsors at last night's European Mediscience Awards 2024 for an enjoyable evening! Autolus Therapeutics are humbled to receive the Capital Market Transaction of the Year Award for our partnership with BioNTech SE and the concurrent capital market transaction that we closed in February this year. Its not every day you close a $600m financing, so we are grateful for the recognition. The biggest thank you goes to our partner BioNTech SE! Nina Hossain, awards presenter; Chris Williams, Chief Business Officer, Autolus Therapeutics; Oliver Haslam, Managing Director, Edison Group (award sponsor); Rob Dolski, Chief Financial Officer, Autolus Therapeutics; and Michael White, Head of Life Sciences and Healthcare, HSBC Innovation Banking (mainline sponsor).
-
-
Huge congratulations to all our incredible winners at last night's European Mediscience Awards 2024, sponsored by HSBC Innovation Banking. We hope you had a wonderful evening celebrating and we look forward to seeing you all again next year! #EMA24 MoonLake Immunotherapeutics (NASDAQ: MLTX) Valneva Tubulis GmbH Brad Loncar BiotechTV Autolus Therapeutics Ruth McKernan Karim Bitar Convatec Zealand Pharma
-
-
Autolus Therapeutics is excited to be at Jefferies Global Healthcare Conference in New York this week. Our CEO Christian Itin is presenting at 7.30am EDT tomorrow, June 6th. To register for the webcast, click here: http://bit.ly/3Kx4LxC #jefferieshealthcare
-
-
For investors and media: Autolus Therapeutics is excited to be attending #ASCO2024 today, and presenting longer term data from our study in adult ALL. Read the details here: https://lnkd.in/eRXseAVk
News
autolus.com
-
Autolus Therapeutics' Chief Technical Officer David Brochu presented to a packed room at the Miltenyi Biotec Corporate Symposium, discussing drug development and commercial manufacturing during ISCT 2024 in Vancouver. Hope to see some of you there! #ISCT2024 #CGT
The world of cell and gene therapy is gathered in Vancouver to experience an exciting first day of insights and exchange at ISCT 2024! We saw an incredible turnout for Matthew Hewitt Tony Barnitz David Brochu who shared lessons learned in drug development and manufacturing at commercial scale. Photo: Miltenyi Biotec Corporate Symposium (chaired by Ian Gaudet) Charles River Laboratories, Adaptimmune, Autolus Therapeutics Looking forward to Day 2! #CGT #cdmo #ISCT2024
-
-
For Investors and Analysts Autolus is delighted to announce three clinical data updates at EHA being held in Madrid from 13 to 16 June: https://lnkd.in/esNBTSjf
-
-
For investors and analysts May 10 marks #WorldLupusDay, a crucial moment to shine a light on this complex autoimmune condition affecting millions globally. We are proud to stand alongside organisations striving to develop solutions and enhance the quality of life for patients globally. Learn more about how you can get involved at https://worldlupusday.org/ #MakeLupusVisible #Awareness #Autolus
Home
http://worldlupusday.org
-
Autolus Therapeutics is absolutely delighted to have been shortlisted for two European Mediscience Awards 2024. We've been shortlisted for Capital Market Transaction of the Year, and our CEO Christian Itin has been shortlisted for Chief Executive of the Year. We're honoured to be shortlisted alongside such impressive companies and CEOs in the European life sciences sector
-
-
Give a warm welcome to the LGBTQ+ Business Community, Autolus Therapeutics! 🌈 We’re excited to be working together to promote diversity and inclusion. Everyone should be able to bring their whole selves to work, and Autolus Therapeutics is joining us to help make it possible. ✅ Find out more about Autolus Therapeutics and apply to their LGBTQ-friendly career opportunities on myGwork: https://lnkd.in/eZSieQH2 #NewPartner #WorkingWithPride #DEI
Chief Development Officer, and Chief Medical Officer, Hematology/Oncology and Supportive Care CAR-T Immunotherapy, Oncolytic Virus Therapy and Next Generation Chemotherapy
4wCongratulations!!!